• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保护儿童风湿性疾病中的骨骼健康:药理学考量

Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

作者信息

Zhang Yujuan, Milojevic Diana

机构信息

Pediatric Rheumatology Division, Floating Hospital for Children at Tufts Medical Center, 800 Washington Street, #190, Boston, MA, 02111, USA.

出版信息

Paediatr Drugs. 2017 Jun;19(3):193-211. doi: 10.1007/s40272-017-0219-3.

DOI:10.1007/s40272-017-0219-3
PMID:28290112
Abstract

Bone health in children with rheumatic conditions may be compromised due to several factors related to the inflammatory disease state, delayed puberty, altered life style, including decreased physical activities, sun avoidance, suboptimal calcium and vitamin D intake, and medical treatments, mainly glucocorticoids and possibly some disease-modifying anti-rheumatic drugs. Low bone density or even fragility fractures could be asymptomatic; therefore, children with diseases of high inflammatory load, such as systemic onset juvenile idiopathic arthritis, juvenile dermatomyositis, systemic lupus erythematosus, and those requiring chronic glucocorticoids may benefit from routine screening of bone health. Most commonly used assessment tools are laboratory testing including serum 25-OH-vitamin D measurement and bone mineral density measurement by a variety of methods, dual-energy X-ray absorptiometry as the most widely used. Early disease control, use of steroid-sparing medications such as disease-modifying anti-rheumatic drugs and biologics, supplemental vitamin D and calcium, and promotion of weight-bearing physical activities can help optimize bone health. Additional treatment options for osteoporosis such as bisphosphonates are still controversial in children with chronic rheumatic diseases, especially those with decreased bone density without fragility fractures. This article reviews common risk factors leading to compromised bone health in children with chronic rheumatic diseases and discusses the general approach to prevention and treatment of bone fragility.

摘要

患有风湿性疾病的儿童的骨骼健康可能会因多种因素而受到损害,这些因素与炎症性疾病状态、青春期延迟、生活方式改变(包括身体活动减少、避免日晒、钙和维生素D摄入不足)以及医学治疗(主要是糖皮质激素,可能还有一些改善病情的抗风湿药物)有关。低骨密度甚至脆性骨折可能没有症状;因此,患有高炎症负荷疾病的儿童,如全身型幼年特发性关节炎、幼年皮肌炎、系统性红斑狼疮,以及那些需要长期使用糖皮质激素的儿童,可能会从常规的骨骼健康筛查中受益。最常用的评估工具是实验室检测,包括血清25-羟基维生素D测量以及通过多种方法进行的骨密度测量,双能X线吸收法是使用最广泛的。早期疾病控制、使用如改善病情的抗风湿药物和生物制剂等减少类固醇用量的药物、补充维生素D和钙,以及促进负重体育活动,有助于优化骨骼健康。对于骨质疏松症的其他治疗选择,如双膦酸盐,在患有慢性风湿性疾病的儿童中,尤其是那些骨密度降低但没有脆性骨折的儿童中,仍然存在争议。本文综述了导致慢性风湿性疾病儿童骨骼健康受损的常见危险因素,并讨论了预防和治疗骨脆性的一般方法。

相似文献

1
Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.保护儿童风湿性疾病中的骨骼健康:药理学考量
Paediatr Drugs. 2017 Jun;19(3):193-211. doi: 10.1007/s40272-017-0219-3.
2
A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.北美儿科风湿病学家对类固醇相关骨质疏松症的诊断、预防和治疗实践的调查。
Pediatr Rheumatol Online J. 2014 Jul 9;12:24. doi: 10.1186/1546-0096-12-24. eCollection 2014.
3
Bone health in pediatric rheumatic disease.儿童风湿性疾病中的骨骼健康
Curr Opin Pediatr. 2005 Dec;17(6):703-8. doi: 10.1097/01.mop.0000184048.13263.88.
4
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.坦桑尼亚一家三级医院儿科风湿性疾病谱。
Pediatr Rheumatol Online J. 2020 Apr 3;18(1):30. doi: 10.1186/s12969-020-0418-2.
5
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.风湿性疾病儿科患者开始使用糖皮质激素后的头三年中发生的椎体骨折及危险因素
J Bone Miner Res. 2015 Sep;30(9):1667-75. doi: 10.1002/jbmr.2511. Epub 2015 May 26.
6
Bone safety of low-dose glucocorticoids in rheumatic diseases.风湿性疾病中低剂量糖皮质激素的骨骼安全性。
Ann N Y Acad Sci. 2014 May;1318:55-64. doi: 10.1111/nyas.12446. Epub 2014 May 9.
7
Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.患有系统性红斑狼疮、幼年皮肌炎和系统性血管炎的儿童及青少年的骨矿物质密度:与疾病持续时间、累积皮质类固醇剂量、钙摄入量及运动的关系
J Rheumatol. 2005 Apr;32(4):729-33.
8
The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature.潜在疾病对风湿性疾病患儿骨折风险和骨密度的影响:当前文献综述
Semin Arthritis Rheum. 2016 Aug;46(1):49-63. doi: 10.1016/j.semarthrit.2016.02.003. Epub 2016 Feb 26.
9
[Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].阿仑膦酸盐可预防风湿性疾病患者的类固醇诱导性骨质疏松症。
Zhonghua Yi Xue Za Zhi. 2008 Jul 15;88(27):1888-91.
10
Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids.患有风湿性疾病的儿童长期使用糖皮质激素后的骨组织形态计量学变化
Pediatr Rheumatol Online J. 2016 Nov 10;14(1):58. doi: 10.1186/s12969-016-0119-z.

引用本文的文献

1
Use of dietary supplements by children and adolescents.儿童和青少年使用膳食补充剂。
J Pediatr (Rio J). 2024 Mar-Apr;100 Suppl 1(Suppl 1):S31-S39. doi: 10.1016/j.jped.2023.09.008. Epub 2023 Oct 28.
2
"Neuroimmunoendocrinology" in Children with Rheumatic Diseases: How Glucocorticoids Are the Orchestra Director.儿童风湿性疾病的神经免疫内分泌学:糖皮质激素如何成为管弦乐队指挥。
Int J Mol Sci. 2023 Aug 25;24(17):13192. doi: 10.3390/ijms241713192.
3
Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.

本文引用的文献

1
Effects of Vitamin D Supplementation on Muscle Strength in Athletes: A Systematic Review.补充维生素D对运动员肌肉力量的影响:一项系统综述。
J Strength Cond Res. 2017 Feb;31(2):566-574. doi: 10.1519/JSC.0000000000001518.
2
Update on Bone Health in Pediatric Chronic Disease.儿童慢性疾病中的骨骼健康最新动态。
Endocrinol Metab Clin North Am. 2016 Jun;45(2):433-41. doi: 10.1016/j.ecl.2016.01.009. Epub 2016 Apr 7.
3
The Association Between Serum 25-hydroxy Vitamin D Level and Upper Leg Strength in Patients with Knee Osteoarthritis: Results of the Amsterdam Osteoarthritis Cohort.
儿童风湿性疾病的骨骼健康:关注分子机制、诊断和管理。
Int J Mol Sci. 2022 May 20;23(10):5725. doi: 10.3390/ijms23105725.
4
Growth and puberty in children with juvenile idiopathic arthritis.幼年特发性关节炎患儿的生长与青春期发育
Pediatr Rheumatol Online J. 2021 Mar 12;19(1):28. doi: 10.1186/s12969-021-00521-5.
5
Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.专家小组共识推荐意见:儿童继发性骨质疏松症的诊断与治疗。
Pediatr Rheumatol Online J. 2020 Feb 24;18(1):20. doi: 10.1186/s12969-020-0411-9.
6
Glucocorticoid treatment in juvenile idiopathic arthritis.幼年特发性关节炎的糖皮质激素治疗。
Rheumatol Int. 2019 Jan;39(1):13-27. doi: 10.1007/s00296-018-4168-0. Epub 2018 Oct 1.
血清25-羟基维生素D水平与膝骨关节炎患者大腿力量的关联:阿姆斯特丹骨关节炎队列研究结果
J Rheumatol. 2016 Jul;43(7):1400-5. doi: 10.3899/jrheum.150751. Epub 2016 May 15.
4
New anti-resorptives and antibody mediated anti-resorptive therapy.新型抗吸收药物及抗体介导的抗吸收治疗
Bone Joint J. 2016 Feb;98-B(2):160-5. doi: 10.1302/0301-620X.98B2.36161.
5
Glucocorticoid-induced Osteoporosis.糖皮质激素性骨质疏松症
Rheum Dis Clin North Am. 2016 Feb;42(1):177-89, x. doi: 10.1016/j.rdc.2015.08.005. Epub 2015 Oct 24.
6
Evaluation of bone mass in children and young adults with juvenile idiopathic arthritis.幼年特发性关节炎患儿及青年骨量评估
Clin Exp Rheumatol. 2015 Sep-Oct;33(5):758-64. Epub 2015 Jul 23.
7
Severe hypercalcemia following denosumab treatment in a juvenile patient.一名青少年患者在接受地诺单抗治疗后出现严重高钙血症。
J Bone Miner Metab. 2016 Jan;34(1):118-22. doi: 10.1007/s00774-015-0677-z. Epub 2015 Jun 9.
8
Combined effects of interaction between physical activity and nutrition on bone health in children and adolescents: a systematic review.身体活动与营养相互作用对儿童和青少年骨骼健康的综合影响:一项系统综述
Nutr Rev. 2015 Mar;73(3):127-39. doi: 10.1093/nutrit/nuu065.
9
Vitamin D—update for the pediatric rheumatologists.维生素D——儿科风湿病学家的最新资讯。
Pediatr Rheumatol Online J. 2015 May 29;13:18. doi: 10.1186/s12969-015-0017-9.
10
Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.质子泵抑制剂的使用与年轻成年人骨折有关:一项基于人群的研究。
Osteoporos Int. 2015 Oct;26(10):2501-7. doi: 10.1007/s00198-015-3168-0. Epub 2015 May 19.